165 related articles for article (PubMed ID: 25675409)
1. ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study).
Xie Q; Hao CM; Ji L; Hu D; Zhu T; Li X; Qin D; Zhang D
PLoS One; 2015; 10(2):e0116970. PubMed ID: 25675409
[TBL] [Abstract][Full Text] [Related]
2. Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial.
Taheri S; Asim M; Al Malki H; Fituri O; Suthanthiran M; August P;
Trials; 2018 Apr; 19(1):230. PubMed ID: 29665833
[TBL] [Abstract][Full Text] [Related]
3. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin blockade on the association between albuminuria and peripheral arterial disease in elderly Taiwanese patients with type 2 diabetes mellitus.
Tseng CH; Tseng CP; Tai TY; Chong CK
Circ J; 2005 Aug; 69(8):965-70. PubMed ID: 16041168
[TBL] [Abstract][Full Text] [Related]
5. Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria.
Chienwichai K; Chaloemwa P; Sangkaew S; Chang A
Clin Nephrol; 2024 Jun; 101(6):277-286. PubMed ID: 38606848
[TBL] [Abstract][Full Text] [Related]
6. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
7. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.
Vejakama P; Thakkinstian A; Lertrattananon D; Ingsathit A; Ngarmukos C; Attia J
Diabetologia; 2012 Mar; 55(3):566-78. PubMed ID: 22189484
[TBL] [Abstract][Full Text] [Related]
8. PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey.
Fici F; Bakir EA; Beyaz S; Makel W; Robles NR
Prim Care Diabetes; 2018 Dec; 12(6):558-564. PubMed ID: 30327190
[TBL] [Abstract][Full Text] [Related]
9. Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Davis TME; Davis WA
Diabetes Care; 2020 Sep; 43(9):2113-2120. PubMed ID: 32616610
[TBL] [Abstract][Full Text] [Related]
10. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Xie J; Liu YM; Zhao YC; Huang X; Lin L; Xia M; Chen MM; Cheng X; Zhang X; Guo D; Peng Y; Ji YX; Chen J; She ZG; Wang Y; Xu Q; Tan R; Wang H; Lin J; Luo P; Fu S; Cai H; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu M; Chen M; Zhang XJ; Wang X; Touyz RM; Xia J; Zhang BH; Huang X; Yuan Y; Loomba R; Liu PP; Li H
Circ Res; 2020 Jun; 126(12):1671-1681. PubMed ID: 32302265
[TBL] [Abstract][Full Text] [Related]
11. Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians.
Park JY; Rha SW; Choi BG; Choi SY; Choi JW; Ryu SK; Lee SJ; Kim S; Noh YK; Akkala RG; Li H; Ali J; Kim JB; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
Yonsei Med J; 2016 Jan; 57(1):180-6. PubMed ID: 26632399
[TBL] [Abstract][Full Text] [Related]
12. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Sternlicht H; Bakris GL
Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of angiotensin II receptor antagonists in a cohort of Dutch patients with type 2 diabetes mellitus (ZODIAC-14).
van Hateren KJ; Landman GW; Groenier KH; Bilo HJ; Kleefstra N
Can J Diabetes; 2015 Apr; 39(2):157-61. PubMed ID: 25523182
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
Shih CJ; Chu H; Ou SM; Chen YT
Int J Cardiol; 2015 Nov; 199():283-9. PubMed ID: 26218587
[TBL] [Abstract][Full Text] [Related]
17. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
Mayyas F; Bataineh W; Jarab A
Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease.
An J; Niu F; Sim JJ
Pharmacotherapy; 2021 Dec; 41(12):998-1008. PubMed ID: 34655484
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
[TBL] [Abstract][Full Text] [Related]
20. High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?
Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
J Gen Intern Med; 2010 Apr; 25(4):298-304. PubMed ID: 20108127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
